Form 8-K - Current report:
SEC Accession No. 0001493152-24-028081
Filing Date
2024-07-17
Accepted
2024-07-17 06:02:27
Documents
16
Period of Report
2024-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49600
2 ex10-84.htm EX-10.84 66178
3 ex99-1.htm EX-99.1 17634
  Complete submission text file 0001493152-24-028081.txt   348370

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bixt-20240715.xsd EX-101.SCH 3085
5 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bixt-20240715_def.xml EX-101.DEF 26179
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bixt-20240715_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bixt-20240715_pre.xml EX-101.PRE 22367
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3559
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 241120895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)